Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-08

FDA Approved: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE — Original Application (QUAGEN PHARMACEUTICALS LLC)

View source ↗

Summary

FDA approved an original application for a generic fixed-dose combination of butalbital, acetaminophen and caffeine from Quagen Pharmaceuticals LLC. The documen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital; acetaminophen; caffeine)

Snippet

ORIG AP for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (BUTALBITAL, ACETAMINOPHEN AND CAFFEINE)